DIAMEDICA THERAPEUTICS INC (DMAC) Stock Balance Sheet
NASDAQ:DMAC - Nasdaq - CA25253X2077 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.59M | 3.02M | 4.54M | 4.73M | 4.71M | |||
| Marketable Securities | 33.73M | 41.12M | 48.35M | 28.77M | 40.41M | |||
| Receivables | 253.00K | 236.00K | 369.00K | 82.00K | 130.00K | |||
| Other Current Assets | 849.00K | 227.00K | 411.00K | 251.00K | 197.00K | |||
| Total Current Assets | 37.42M | 44.61M | 53.67M | 33.84M | 45.44M | |||
| Non-Current Assets | ||||||||
| PPE Net | 408.00K | 427.00K | 485.00K | 560.00K | 112.00K | |||
| Other Non-Current Assets | 1.00M | 1.31M | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.41M | 1.74M | 485.00K | 560.00K | 112.00K | |||
| TOTAL ASSETS | 38.83M | 46.34M | 54.16M | 34.40M | 45.55M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 12.00K | 13.00K | 3.00K | 6.00K | 4.00K | |||
| Accrued Expenses | 3.15M | 4.44M | 1.86M | 1.43M | 1.01M | |||
| Accounts Payable | 1.51M | 940.00K | 926.00K | 734.00K | 509.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 4.67M | 5.39M | 2.79M | 2.17M | 1.52M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 10.00K | 12.00K | 1.00K | 4.00K | 3.00K | |||
| Other Non-Current Liabilities | 201.00K | 225.00K | 316.00K | 396.00K | 0.00 | |||
| Total Non-Current Liabilities | 211.00K | 237.00K | 317.00K | 400.00K | 3.00K | |||
| TOTAL LIABILITIES | 4.88M | 5.63M | 3.10M | 2.57M | 1.53M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -147.71M | -140.00M | -115.56M | -96.18M | -82.50M | |||
| Additional Paid In Capital | 181.66M | 180.70M | 166.61M | 128.08M | 126.58M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 5.00K | 23.00K | 6.00K | -74.00K | -51.00K | |||
| Shares Outstanding | 42.86M | 42.82M | 37.96M | 26.44M | 26.44M | |||
| Tangible Book Value per Share | 0.79 | 0.95 | 1.35 | 1.20 | 1.66 | |||
| Total Shareholders' Equity | 33.95M | 40.72M | 51.06M | 31.83M | 44.02M | |||
| TOTAL LIABILITIES AND EQUITY | 38.83M | 46.34M | 54.16M | 34.40M | 45.55M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 8.02 | 8.28 | 19.27 | 15.61 | 29.82 | |||
| Return On Assets (ROA) | -69.53% | -52.74% | -35.78% | -39.76% | -29.84% | |||
| Return On Equity (ROE) | -79.52% | -60.03% | -37.96% | -42.97% | -30.87% | |||
All data in USD , ROIC based on taxRate of 0.21